Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the Overall Response Rate (ORR) of oral vinorelbine (Navelbine Oral) in combination with capecitabine (Xeloda) and i.v. trastuzumab (Herceptin) for HER2 positive patients.
Critère d'inclusion
- Treatment in women with previously untreated HER2 positive metastatic breast cancer